Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 15M | 19M |
| Cost of revenue | 8M | 9M |
| Gross profit | 7M | 9M |
| Research and development | 4M | 5M |
| Selling, general and administrative | 2M | 3M |
| Operating expenses | 11M | 12M |
| Operating income | −3M | −2M |
| Interest expense | −496,587 | −330,849 |
| Income tax | −11M | 551,000 |
| Net income | −14M | −2M |
| Earnings per share | −1.81 | −0.30 |
| Earnings per share, diluted | −1.81 | −0.30 |
| Weighted average shares | 8M | 8M |
| Weighted average shares, diluted | 8M | 8M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2M | 2M | 2M | 3M | 2M | 2M | 3M | 2M |
| Receivables | 2M | 2M | 2M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −1M | −521,485 |
| Depreciation and amortisation | 1M | 1M |
| Share-based compensation | 669,198 | 1M |
| Capital expenditure | 537,135 | 788,325 |
| Investing cash flow | −537,135 | −715,525 |
| Financing cash flow | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2M |
| 2M |
| 2M |
| 1M |
| 3M |
| Inventory | 4M | 4M | 5M | 5M | 5M | 5M | 5M | 5M |
| Current assets | 8M | 9M | 9M | 10M | 10M | 10M | 10M | 11M |
| Property, plant and equipment | 2M | 2M | 2M | 2M | 3M | 3M | 3M | 3M |
| Total assets | 14M | 14M | 26M | 27M | 27M | 27M | 28M | 28M |
| Current liabilities | 9M | 8M | 8M | 8M | 8M | 7M | 7M | 7M |
| Total liabilities | 10M | 10M | 10M | 10M | 10M | 9M | 10M | 9M |
| Equity | 4M | 4M | 16M | 17M | 17M | 18M | 18M | 19M |
| Shares outstanding | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M |
| Shares issued | 9M | 8M | 8M | 8M | 8M | 8M | 8M | 8M |
| Treasury shares | — | 359,250 | — | — | — | 359,250 | — | — |
| 902,344 |